Related Experiment Video
Updated: Jun 15, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion tensor imaging reliably differentiates patients with schizophrenia from healthy volunteers
Babak A Ardekani1, Ali Tabesh, Serge Sevy
1Center for Advanced Brain Imaging, The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA. ardekani@nki.rfmh.org
Human Brain Mapping
|March 6, 2010
Summary
Diffusion tensor imaging (DTI) using fractional anisotropy (FA) and mean diffusivity (MD) maps can reliably differentiate schizophrenia patients from healthy individuals. This neuroimaging technique shows high accuracy in distinguishing between these groups.
Area of Science:
- Neuroimaging
- Radiology
- Psychiatry
Background:
- Schizophrenia is a complex psychiatric disorder with underlying neurobiological alterations.
- Diffusion tensor imaging (DTI) provides insights into brain microstructure by measuring water diffusion.
Purpose of the Study:
- To evaluate the efficacy of fractional anisotropy (FA) and mean diffusivity (MD) maps derived from DTI in differentiating schizophrenia patients from healthy controls.
- To assess the diagnostic potential of automated pattern recognition algorithms applied to DTI-derived metrics.
Main Methods:
- Acquisition of DTI and structural MRI scans from 50 schizophrenia patients and 50 healthy volunteers.
- Estimation and spatial normalization of FA and MD maps.
- Development of a Fisher's linear discriminant analysis (LDA) classifier using a training set and validation on a separate test set.
Main Results:
- The classifier achieved 94% accuracy using FA maps (96% sensitivity, 92% specificity).
- The classifier achieved 98% accuracy using MD maps (96% sensitivity, 100% specificity).
- Combined FA and MD data did not significantly improve classification accuracy.
Conclusions:
- DTI-derived FA and MD maps, when analyzed with pattern recognition algorithms, can reliably distinguish schizophrenia patients from healthy subjects.
- These quantitative imaging biomarkers hold promise for objective diagnostic tools in schizophrenia research.

